Literature DB >> 8461545

Estrogen: effects and actions in osteoporosis.

R Lindsay1, F Cosman, J Nieves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461545     DOI： 10.1007/bf01621892

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  19 in total

1.  Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.

Authors:  F Al-Azzawi; D M Hart; R Lindsay
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

2.  A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.

Authors:  T Steiniche; C Hasling; P Charles; E F Eriksen; L Mosekilde; F Melsen
Journal:  Bone       Date:  1989       Impact factor: 4.398

3.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

4.  Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.

Authors:  R Lindsay; D M Hart; D Purdie; M M Ferguson; A S Clark; A Kraszewski
Journal:  Clin Sci Mol Med       Date:  1978-02

5.  Antifracture efficacy of long-term estrogens for osteoporosis.

Authors:  G S Gordan; J Picchi; B S Roof
Journal:  Trans Assoc Am Physicians       Date:  1973

Review 6.  A unified concept of osteoporosis.

Authors:  R P Heaney
Journal:  Am J Med       Date:  1965-12       Impact factor: 4.965

7.  Prevention of osteoporosis by medroxyprogesterone acetate in postmenopausal women.

Authors:  S G McNeeley; J S Schinfeld; T G Stovall; F W Ling; B H Buxton
Journal:  Int J Gynaecol Obstet       Date:  1991-03       Impact factor: 3.561

8.  The minimum effective dose of estrogen for prevention of postmenopausal bone loss.

Authors:  R Lindsay; D M Hart; D M Clark
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

9.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

10.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

Authors:  B L Riggs; E Seeman; S F Hodgson; D R Taves; W M O'Fallon
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245
View more
  2 in total

Review 1.  Aromatase inhibitor-associated bone loss: clinical considerations.

Authors:  Shubham Pant; Charles L Shapiro
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Induction of osteoporosis with its influence on osteoporotic determinants and their interrelationships in rats by DEXA.

Authors:  Christian Heiss; Parameswari Govindarajan; Gudrun Schlewitz; Nasr Y A Hemdan; Nathalie Schliefke; Volker Alt; Ulrich Thormann; Katrin Susanne Lips; Sabine Wenisch; Alexander C Langheinrich; Daniel Zahner; Reinhard Schnettler
Journal:  Med Sci Monit       Date:  2012-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.